According to Pulse Biosciences
's latest financial reports the company has a price-to-book ratio of 10.0.
The price-to-book ratio is a way to measure how much the stock market thinks a company is worth compared to how much the company says its assets are worth on paper.
Year | P/B ratio | Change |
---|---|---|
2023-12-31 | 15.2 | -133.13% |
2022-12-31 | -45.9 | -473.08% |
2021-12-31 | 12.3 | -53.44% |
2020-12-31 | 26.4 | 190.69% |
2019-12-31 | 9.09 | 155.38% |
2018-12-31 | 3.56 | -57.57% |
2017-12-31 | 8.38 | 145.08% |
2016-12-31 | 3.42 | |
2015-12-31 | N/A |
Company | P/B ratio | differencediff. | Country |
---|---|---|---|
PAVmed
PAVM | -0.8554 | -108.54% | ๐บ๐ธ USA |
Philips PHG | 1.82 | -81.87% | ๐ณ๐ฑ Netherlands |